Breast Biopsy Devices Market By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits), Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy), Technique (Image Guided Biopsy, Liquid Biopsy), & Region for 2024-2031

Published Date: July - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Breast Biopsy Devices Market By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits), Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy), Technique (Image Guided Biopsy, Liquid Biopsy), & Region for 2024-2031

Breast Biopsy Devices Market Valuation – 2024-2031

Insurance coverage and government reimbursement policies for breast cancer diagnosis play an important role. Broader insurance coverage for breast biopsies makes the treatment more accessible to a wider patient population. The increasing government initiative and reimbursement policies are driving the growth of market size to surpass USD 2.12 Billion in 2024, to reach a valuation of USD 3.02 Billion by 2031.

The increased preference for minimally invasive techniques over standard surgical biopsies is a major motivator. Newer biopsy devices include smaller needles, shorter recovery times, and less discomfort for patients, making them an appealing option. The growing preference for minimally invasive procedures is enabling the market to grow at a CAGR of 4.50% from 2024 to 2031.

Breast Biopsy Devices MarketDefinition/ Overview

A breast biopsy devices is a specialized medical instrument that extracts a tissue sample from the breast during a biopsy surgery. These devices are classified into numerous varieties based on the type of biopsy being conducted. The most common breast biopsy devices are core biopsy needles, fine needle aspiration needles, vacuum-assisted biopsy needles, stereotactic biopsy devices, and ultrasound probes. Breast biopsy devices need less invasive procedures, allowing doctors to obtain reliable diagnoses, and allowing them to adopt focused treatment strategies quickly. Biopsy technology is continually pushing the boundaries, providing improved accuracy, minimally invasive techniques, and rapid diagnosis.

When it comes to tackling breast cancer, finding it early is key, and breast biopsy devices are our first line of defense. These aren't just tools; they're essential for getting those crucial tissue samples that help doctors make the right diagnosis, so they can plan the best course of action. What's fueling the growth of this market? Well, there's the unfortunate rise in breast cancer cases globally, plus more and more people understand how vital early detection is. And let's not forget the amazing advancements in biopsy tech! The focus on minimally invasive procedures, getting more accurate results faster, and keeping patients comfortable is shaking things up in the Breast Biopsy Devices Market. This creates a ton of opportunity to improve patient care, personalize treatments, and even expand into new markets in developing countries.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How the Rising Prevalence of Breast Cancer in Women and Growing Awareness of Breast Cancer is Driving the Growth of Breast Biopsy Devices?

The breast biopsy market is really taking off, largely because breast cancer is becoming more common worldwide. It's often found in older women who have things like genetic mutations, dense breast tissue, or a family history of breast or ovarian cancer. Did you know that in 2022, a staggering 2.3 million women were diagnosed with breast cancer, and sadly, 670,000 of them passed away? According to the , breast cancer is actually the most common cancer for women in a whopping 157 out of 185 countries as of 2022. And, as the notes, the mortality rate is around 2.5% each year. What's also contributing is the growing number of older folks; breast cancer tends to show up in women over 40, especially after menopause. An aging population, like the 761 million geriatric people globally in 2021, unfortunately fuels these numbers. As the pointed out, in 2020, Asia alone was estimated to have a geriatric population of around 4.5 billion!

More and more people around the world are becoming aware of breast cancer, and that's really increasing the need for devices used in breast biopsies. This awareness isn't just about knowing that breast cancer is dangerous, it's about understanding the symptoms and why it's so important to get checked out if you have any concerns. Working together with cancer survivors, advocacy groups, and local communities is key to getting the right message out there. And for breast cancer programs in less wealthy countries, it's vital to have a clear plan that works with the resources they have, so they can build up their care services step by step. In wealthier countries, mammogram screenings have proven to help lower the number of deaths from breast cancer.

Cancer biopsies are getting a serious tech upgrade, and it's catching on big time, especially with experts and in developed countries. Think about itpositron emission tomography (PET) lets doctors actually see blood flow in specific organs! It's like having both a map and a user's guide, showing function and anatomy. Plus, it's way better at spotting cancer spreading through lymph nodes than older imaging methods. And then there's computed tomography (CT), which uses a bunch of X-rays from different angles to build a picture. It's super fast, which means less blur from movement, giving doctors clearer spatial information to build digital X-rays. Don't forget magnetic resonance imaging (MRI) – the contrast stuff they use in MRIs is also less likely to cause allergic reactions than the iodine-based stuff. And get thiswith magnetic resonance spectroscopy (MRS), you can get all sorts of details - biological, physiological, anatomical, and metabolic information all in one go!

Also, the image-guided technologies are driving growth in the market. Breast biopsies are becoming more precise and efficient thanks to advances in image-guided technology like ultrasonography and stereotactic guidance systems. These advances allow for more precise targeting of questionable tissue samples, reducing the possibility of problems and the need for additional treatments. Mammotome or Vacora biopsies can be performed using ultrasound instead of a mammography. These techniques are comparable to stereotactic biopsy but include lying on your back with no compression or X-rays.

How the High Cost Associated with the Cancer Biopsy is Limiting the Growth of the Breast Biopsy Devices Market?

Advanced biopsy devices can be costly to purchase and operate. This can reduce accessibility, especially in areas with limited healthcare resources or for patients with limited insurance coverage. Biopsies cost between $307 for a tiny needle biopsy and $3,296 for a sophisticated surgical biopsy, with other biopsies costing $12,353. Mediastinum biopsies cost an average of $10,554. The cost of a vacuum-assisted biopsy is USD 264 per case.

The future of cancer biopsy devices could be shaken up by liquid biopsies. These tests analyze cancer cells circulating in the blood and, while not meant to replace traditional biopsies entirely, might become a screening tool. This could mean fewer times doctors need to take tissue samples, which is great news for patients since liquid biopsies are much less invasive – just a simple blood draw! However, as AI and other digital technologies find their way into biopsy instruments, data security becomes a major concern. We're talking about sensitive patient info potentially being stored and shared online, so rock-solid cybersecurity is crucial. This means implementing safeguards to keep out unauthorized users, preventing those dreaded data breaches, protecting patient privacy, and making sure medical data stays accurate. Bottom line? Hospitals and device companies need to invest in top-notch security and always be improving their systems to stay ahead of the latest threats in the digital world.

In addition, compliance with regulatory standards such as HIPAA (Health Insurance Portability and Accountability Act) is critical for maintaining patient confidentiality and trust in medical practices. By emphasizing data security, healthcare practitioners can confidently use AI and digital technologies to improve diagnostic accuracy and patient care while reducing the dangers of illegal access to sensitive medical information.

Category-Wise Acumens

How the Technological Advancements in the Biopsy Device Market are Driving the Growth of the Biopsy Needles Segment?

The biopsy needles segment is showing substantial growth in the Breast Biopsy Devices Market and is expected to continue its growth throughout the forecast period thanks to the technological advancements and the new product launches that are driving the growth of the biopsy needles segment in the market. The biopsy needle’s thin design allows for minimally invasive operations, which reduces patient discomfort, recuperation time, and complications. This minimally invasive nature also enables outpatient operations, which improves patient convenience. Versatility is another important asset.

Biopsy needles come in a variety of sizes, each designed to collect distinct types of tissue samples based on the location and characteristics of the suspicious area. Core biopsy needles extract bigger tissue cores for a thorough investigation, whereas fine-needle aspiration needles obtain a preliminary diagnosis from a smaller sample. Vacuum-assisted needles provide a compromise, gathering larger samples than ordinary core needles. Furthermore, biopsy needles are often less expensive than surgical biopsy equipment, making the treatment available to a wider spectrum of patients.

Also, many biopsy needles work perfectly with image-guided systems such as ultrasonography and stereotactic methods. This real-time imaging of targeted tissue increases sample collection accuracy and lowers the need for additional biopsies. To summarize, biopsy needles are a critical component of cancer biopsy equipment, offering a safe, effective, and cost-effective method of collecting tissue samples for accurate diagnosis.

How the Minimally Invasive Molecular Monitoring of Liquid Biopsy is Driving the Growth of the Breast Biopsy Devices Market?

When it comes to breast biopsy devices, liquid biopsy is really taking the lead! It's becoming a popular choice for keeping an eye on cancer because it's not very invasive. You see, unlike the usual tissue biopsies that need more, well, intrusive procedures, liquid biopsy is way gentler. It just collects body fluids, usually blood from your arm – much less stressful, right? This amazing technique lets us measure all sorts of genetic stuff that tumor cells release into the bloodstream. We're talking about things like circulating tumor cells (CTCs), cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA), circulating tumor RNA, extracellular vesicles (EVs), circulating tumor proteins, and even tumor-educated platelets (TEPs)! All this information gives us a much better idea of what's going on with the tumor at a molecular level.

Liquid biopsy has the advantage of being easier to serially evaluate than standard tissue biopsies. With liquid biopsy, practitioners can perform repeated tests over time with minimum discomfort to the patient, allowing for constant monitoring of disease progression and treatment response. Liquid biopsy, when paired with very sensitive molecular technology and modern bioinformatics techniques, can reveal intra-tumoral heterogeneity (spatial heterogeneity) as well as the molecular evolution of distant metastatic lesions. This is especially useful because standard tissue biopsies may not capture the entire spectrum of tumor cells found in heterogeneous tumors.

Unlike tissue biopsies, which may not accurately reflect the entire tumor, liquid biopsy provides a more comprehensive sampling of genetic elements generated by multiple tumor cells circulating in the bloodstream. This reduces the likelihood of non-representative biopsy specimens and gives a more accurate picture of the tumor’s genetic landscape.

Gain Access to Breast Biopsy Devices Market Report Methodology

Country/Region-wise Acumens

How will the Market Fare in North America?

North America is really leading the way in the Breast Biopsy Devices Market, and we expect that to stay strong. What's driving this? Well, technology keeps getting better, leading to more accurate and less invasive breast biopsy techniques. This means better diagnoses and happier patients, because biopsies are becoming easier and faster. Plus, we're seeing more breast cancer cases in North America, unfortunately, which naturally creates a greater need for better ways to diagnose it. For example, according to the National Breast Cancer Foundation, in the United States in 2020 239,612 breast cancer cases were registered and 42,273 females died in 2020 due to breast cancer. Because people are also more aware of breast health and the importance of early detection, there's a big push for quick and accurate diagnoses, which ultimately increases the demand for these biopsy technologies.

Favorable reimbursement conditions in the region have made breast biopsy procedures more accessible to patients. Healthcare regulations and insurance coverage schemes have facilitated the adoption of new diagnostic technology, encouraging both healthcare providers and patients to choose these operations. The new breast density notification rules in the United States have expanded the use of breast biopsy technologies. These regulations oblige healthcare providers to educate people about their breast density and the consequences of cancer detection, resulting in increased proactive screening methods and the use of modern biopsy techniques.

Competitive Landscape

The Breast Biopsy Devices Market is competitive and dynamic, with companies continuously striving to innovate and differentiate their offerings to meet the evolving needs of healthcare providers and patients. Collaboration with healthcare professionals and investment in research and development are key strategies for maintaining competitiveness in this rapidly advancing field.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Breast Biopsy Devices Market include

  • Aspen Surgical Products Company
  • Deviceph
  • INRAD
  • Epredia
  • Miltenyi Biotec
  • Vacuumassister®
  • IBreast Imaging Systems, Ltd.
  • iGenomix
  • EndoChoice, Inc.
  • Endosight Corporation

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2021-2031

Growth Rate

CAGR of ~4.50% from 2024 to 2031

Base Year for Valuation

2024

Historical Period

2021-2023

Forecast Period

2024-2031

Quantitative Units

Value in USD Billion

Report Coverage

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

Segments Covered
  • Type
  • Procedure
  • Technique
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players

Aspen Surgical Products Company, Deviceph, INRAD, Epredia, Miltenyi Biotec, Vacuumassister®, IBreast Imaging Systems, Ltd., iGenomix, EndoChoice, Inc., Endosight Corporation

Customization

Report customization along with purchase available upon request

Breast Biopsy Devices Market, By Category

Type

  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits

Procedure

  • Needle Breast Biopsy
  • Open Surgical Breast Biopsy
  • Liquid Breast Biopsy

Technique

  • Image Guided Biopsy
  • Liquid Biopsy

Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dig into the market using both number-crunching (quantitative) and understanding the "why" behind the numbers (qualitative), breaking things down by different segments based on money and other things. We'll give you the market value in USD Billion for each of these segments and sub-segments. We'll also point out which region and segment we think will grow the fastest and be the biggest. You'll get a breakdown by geography, showing how much of the product/service is used in each area, and what's influencing the market there. Plus, we'll map out the competitive landscape, ranking the big players and detailing their new offerings, alliances, expansions, and acquisitions over the last five years, with detailed profiles including company insights, product comparisons, and SWOT analyses. We'll paint a picture of the industry's present and future, looking at recent developments, growth opportunities, driving forces, and the challenges faced by both new and established regions. You'll also get a deep dive using Porter's five forces, a look at the Value Chain, and an exploration of market dynamics, including growth opportunities in the future. Oh, and we'll even provide 6 months of analyst support after the sale!

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Pivotal Questions Answered in the Study

Some of the key players leading in the market include Aspen Surgical Products Company, Deviceph, INRAD, Epredia, Miltenyi Biotec, Vacuumassister, IBreast Imaging Systems, Ltd., iGenomix, EndoChoice, Inc., and Endosight Corporation
Insurance coverage and government reimbursement policies for breast cancer diagnosis play an important role. Broader insurance coverage for breast biopsies makes the treatment more accessible to a wider patient population and is propelling the demand for the adoption of the Breast Biopsy Devices Market.
Advanced biopsy devices can be costly to purchase and operate. This can reduce accessibility, especially in areas with limited healthcare resources or for patients with limited insurance coverage limiting the growth of the Breast Biopsy Devices Market.
The Breast Biopsy Devices Market is estimated to grow at a CAGR of 4.50% during the forecast period.

Related Reports

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email